Literature DB >> 11504714

Structure of a neutral glycosphingolipid recognized by human antibodies in polyagglutinable erythrocytes from the rare NOR phenotype.

M Duk1, B B Reinhold, V N Reinhold, G Kusnierz-Alejska, E Lisowska.   

Abstract

NOR is a rare inheritable polyagglutination phenomenon that has been described in two families. Our recent studies on these erythrocytes showed they contained at least two unique neutral glycosphingolipids, and based on their reactivity with Griffonia simplicifolia IB4 (GSL-IB4) isolectin (Kusnierz-Alejska, G., Duk, M., Storry, J. R., Reid, M. E., Wiecek, B., Seyfried, H., and Lisowska, E. (1999) Transfusion 39, 32-38), both oligosaccharide chains terminated with an alpha-galactose residue. The reactivity with GSL-IB4 suggested that these oligosaccharide chains terminated with a Galalpha1-->3Gal- sequence and that anti-NOR agglutinins were common human anti-Galalpha1-->3Gal xenoantibodies. In this report we describe the structure of one NOR component (NOR1) that migrated on thin-layer chromatographic plates in the region of pentaglycosylceramides. Treatment of this sample with alpha-galactosidase and beta-N-acetylhexosaminidase was followed by high-performance thin-layer chromatography with product detection by lectins and the anti-Gb4 monoclonal antibody. The results suggested that NOR1 was an alpha-galactosylated Gb4Cer with a beta-N-acetylhexosaminidase-resistant GalNAc residue. Gas phase disassembly by ion trap mass spectrometry analysis showed the sequence to be Hex1-->4HexN1-->3Hex1-->4Hex1-->4Hex linked to a ceramide composed of C18 sphingosine and a C24 monounsaturated fatty acid. Together these data indicate NOR1 to be a novel Galalpha1-->4GalNAcbeta1-->3Galalpha1-->4Galbeta1-->4 Glc-Cer structure. Additionally it has been shown that NOR glycolipids are recognized by human antibodies that were distinct from the known anti-Galalpha1-->3Gal xenoantibodies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11504714     DOI: 10.1074/jbc.M102711200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Presence of natural anti-Galalpha1-4GalNAcbeta1-3Gal (anti-NOR) antibodies in animal sera.

Authors:  Maria Duk; Elwira Lisowska
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

2.  A single point mutation in the gene encoding Gb3/CD77 synthase causes a rare inherited polyagglutination syndrome.

Authors:  Anna Suchanowska; Radoslaw Kaczmarek; Maria Duk; Jolanta Lukasiewicz; Dorota Smolarek; Edyta Majorczyk; Ewa Jaskiewicz; Anna Laskowska; Kazimiera Wasniowska; Magdalena Grodecka; Elwira Lisowska; Marcin Czerwinski
Journal:  J Biol Chem       Date:  2012-09-10       Impact factor: 5.157

Review 3.  Lectins as tools in glycoconjugate research.

Authors:  Albert M Wu; Elwira Lisowska; Maria Duk; Zhangung Yang
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

4.  Evaluation of an amino acid residue critical for the specificity and activity of human Gb3/CD77 synthase.

Authors:  Radoslaw Kaczmarek; Katarzyna Mikolajewicz; Katarzyna Szymczak; Maria Duk; Edyta Majorczyk; Anna Krop-Watorek; Anna Buczkowska; Marcin Czerwinski
Journal:  Glycoconj J       Date:  2016-08-18       Impact factor: 2.916

5.  Single nucleotide polymorphisms in A4GALT spur extra products of the human Gb3/CD77 synthase and underlie the P1PK blood group system.

Authors:  Radoslaw Kaczmarek; Katarzyna Szymczak-Kulus; Anna Bereźnicka; Krzysztof Mikołajczyk; Maria Duk; Edyta Majorczyk; Anna Krop-Watorek; Elżbieta Klausa; Joanna Skowrońska; Bogumiła Michalewska; Ewa Brojer; Marcin Czerwinski
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.